FDA.reportPublic FDA data

Rylaze 10 MG per 0.5 ML Injection

RxCUI
2561256
RxNorm name
Rylaze 10 MG per 0.5 ML Injection
Display name
Rylaze 10 MG per 0.5 ML Injection
Full name
Rylaze 10 MG per 0.5 ML Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:07

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761179Rylazeasparaginase erwinia chrysanthemi (recombinant)-rywn351(a)Rx2026-07-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
RylazeASPARAGINASE ERWINIA CHRYSANTHEMI (RECOMBINANT)-RYWNJazz Pharmaceuticals, Inc.857e53aa-1098-4dad-b654-0276cdd43e032025-07-01Warnings, Adverse reactionsExact identifier
rxcui: 2561256

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
857e53aa-1098-4dad-b654-0276cdd43e03RYLAZE 10 MG in 0.5 ML Injection [PSN] · 0.5 ML asparaginase Erwinia chrysanthemi (recombinant)-rywn 20 MG/ML Injection [Rylaze] [SBD] · 0.5 ML Rylaze 20 MG/ML Injection [SY] · Rylaze 10 MG per 0.5 ML Injection [SY]47These highlights do not include all the information needed to use RYLAZE safely and effectively. See full prescribing information for RYLAZE. RYLAZE ® (asparaginase erwinia chrysanthemi (recombinant)-rywn) injection, for intramuscular use Initial U.S. Approval: 202120250701